Wendy Stock to Feasibility Studies
This is a "connection" page, showing publications Wendy Stock has written about Feasibility Studies.
Connection Strength
0.007
-
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood. 1996 Oct 01; 88(7):2665-70.
Score: 0.007